Form 4 for KURA Kura Oncology, Inc.
Accepted 2025-09-29 00:00:00 ET · period of report 2025-09-27 · accession 0001193125-25-223663 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-29 | 2025-09-27 | KURA | WILSON TROY EDWARD | Pres, CEO, Dir | A - Grant | $0.00 | +182.5K | 283.5K | +181% | $0 | |
| 2025-09-29 | 2025-09-29 | KURA | WILSON TROY EDWARD | Pres, CEO, Dir | S - Sale | $8.94 | -36.6K | 246.9K | -13% | -$327.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-27 | A | A | 182,500 | $0.00 | 283,468 | D | — | — | |
| 2 | Common | Common Stock | 2025-09-29 | S | D | 36,615 | $8.94 | 246,853 | D | — | — |